A carregar...
Measurement of quality of life in second-line patients with advanced NSCLC without targetable mutations: a review
Quality of life (QoL) is important to cancer patients and is increasingly included as a trial end point. The methodologies/findings of randomized controlled trials evaluating the efficacy and safety of second-line treatments approved for use in the EU in patients with advanced/metastatic NSCLC, with...
Na minha lista:
| Publicado no: | Lung Cancer Manag |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6310313/ https://ncbi.nlm.nih.gov/pubmed/30643554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/lmt-2016-0010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|